Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53 - PubMed (original) (raw)
. 2001 Jan 11;20(2):147-55.
doi: 10.1038/sj.onc.1204062.
Affiliations
- PMID: 11313944
- DOI: 10.1038/sj.onc.1204062
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53
S S Bacus et al. Oncogene. 2001.
Abstract
The anti-cancer agent paclitaxel (Taxol) stabilizes microtubules leading to G2/M cell cycle arrest and apoptotic cell death. In order to analyse the molecular mechanisms of Taxol-induced cytotoxicity, we studied the involvement of mitogen-activated protein kinases (MAPK) ERK and p38 as well as the p53 pathways in Taxol-induced apoptosis. The human breast carcinoma cell line MCF7 and its derivatives, MCF7/HER-2 and MDD2, were used in the study. We found that Taxol treatment strongly activated ERK, p38 MAP kinase and p53 in MAP kinase MCF7 cells prior to apoptosis. PD98059 or SB203580, specific inhibitors of ERK and p38 kinase activities, significantly decreased apoptosis, leaving the surviving cells arrested in G2/M. These inhibitors did not significantly affect Taxol-induced alterations in the cell cycle regulatory proteins Rb, p53, p21/Waf1 and Cdk-2. In addition, inactivation of p53 did not affect cellular sensitivity to Taxol killing. However, cells with inactivated p53, unlike cells harboring wild type p53, failed to arrest in G2/M after treatment with Taxol and continued to divide or go into apoptosis. Our data show that both ERK and p38 MAP kinase cascades are essential for apoptotic response to Taxol-induced cellular killing and are independent of p53 activity. However, p53 may serve as a survival factor in breast carcinoma cells treated with Taxol by blocking cells in G2/M phase of the cell cycle.
Similar articles
- CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
Lee AW, Nambirajan S, Moffat JG. Lee AW, et al. Oncogene. 1999 Dec 9;18(52):7477-94. doi: 10.1038/sj.onc.1203123. Oncogene. 1999. PMID: 10602507 - Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
Garner AP, Weston CR, Todd DE, Balmanno K, Cook SJ. Garner AP, et al. Oncogene. 2002 Nov 21;21(53):8089-104. doi: 10.1038/sj.onc.1206000. Oncogene. 2002. PMID: 12444545 - Molecular effects of paclitaxel: myths and reality (a critical review).
Blagosklonny MV, Fojo T. Blagosklonny MV, et al. Int J Cancer. 1999 Oct 8;83(2):151-6. doi: 10.1002/(sici)1097-0215(19991008)83:2<151::aid-ijc1>3.0.co;2-5. Int J Cancer. 1999. PMID: 10471519 Review. - Polyamine analogue-mediated cell cycle responses in human melanoma cells involves the p53, p21, Rb regulatory pathway.
Kramer DL, Vujcic S, Diegelman P, White C, Black JD, Porter CW. Kramer DL, et al. Biochem Soc Trans. 1998 Nov;26(4):609-14. doi: 10.1042/bst0260609. Biochem Soc Trans. 1998. PMID: 10047792 Review. No abstract available.
Cited by
- Tyrosol prevents ischemia/reperfusion-induced cardiac injury in H9c2 cells: involvement of ROS, Hsp70, JNK and ERK, and apoptosis.
Sun L, Fan H, Yang L, Shi L, Liu Y. Sun L, et al. Molecules. 2015 Feb 25;20(3):3758-75. doi: 10.3390/molecules20033758. Molecules. 2015. PMID: 25723850 Free PMC article. - Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells.
Zhu K, Gerbino E, Beaupre DM, Mackley PA, Muro-Cacho C, Beam C, Hamilton AD, Lichtenheld MG, Kerr WG, Dalton W, Alsina M, Sebti SM. Zhu K, et al. Blood. 2005 Jun 15;105(12):4759-66. doi: 10.1182/blood-2004-11-4307. Epub 2005 Feb 22. Blood. 2005. PMID: 15728126 Free PMC article. - Multiscale modeling of tumor response to vascular endothelial growth factor (VEGF) inhibitor.
Hendrata M, Sudiono J. Hendrata M, et al. In Silico Biol. 2021;14(3-4):71-88. doi: 10.3233/ISB-210235. In Silico Biol. 2021. PMID: 35001886 Free PMC article. - Targeting prostate cancer based on signal transduction and cell cycle pathways.
Lee JT, Lehmann BD, Terrian DM, Chappell WH, Stivala F, Libra M, Martelli AM, Steelman LS, McCubrey JA. Lee JT, et al. Cell Cycle. 2008 Jun 15;7(12):1745-62. doi: 10.4161/cc.7.12.6166. Epub 2008 Jun 16. Cell Cycle. 2008. PMID: 18594202 Free PMC article. Review. - Wentilactone A as a novel potential antitumor agent induces apoptosis and G2/M arrest of human lung carcinoma cells, and is mediated by HRas-GTP accumulation to excessively activate the Ras/Raf/ERK/p53-p21 pathway.
Lv C, Hong Y, Miao L, Li C, Xu G, Wei S, Wang B, Huang C, Jiao B. Lv C, et al. Cell Death Dis. 2013 Dec 5;4(12):e952. doi: 10.1038/cddis.2013.484. Cell Death Dis. 2013. PMID: 24309939 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous